Maravai Lifesciences Holdings, Inc. (MRVI) fundamentals score
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Its customers include biopharmaceutical companies, emerging biotech firms, life science research organizations, academic research institutions and diagnostics companies.
Pharmaceutical Preparations · Healthcare · Listed on NASDAQ
Overall: 4.0 out of 10, Weak long-term fundamentals
- Growth: 3.0/10
- Profitability: 3.5/10
- Financial health: 4.3/10
- Earnings quality: 7.7/10
- Valuation: 2.4/10
Scores are calculated from Maravai Lifesciences Holdings, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10